‍

‍

‍

This month, we are pleased to spotlight Peter Park, Founder and Co-CEO at Alchemy.

‍

‍

‍

Please include a brief first-person bio, including a description of your current role and Alchemy.

I’m the Founder & Co-CEO of Alchemy, a healthtech company that builds and operates in-house pharmacies for safety-net clinics across the U.S. We provide the physical, clinical, and digital pharmacy infrastructure that enables clinics to reclaim control of their 340B programs, ensure access to essential medicines for their patients, and integrate wrap-around services that strengthen community health.

‍

Why do you believe it's important for businesses to play a role in our nation's efforts to end the HIV epidemic?

The U.S. Business Action to End HIV Coalition highlights the many ways businesses can and do contribute. What makes this moment especially exciting is that we now have breakthroughs that simply didn’t exist even months ago—a twice-annual injectable that provides nearly full protection against HIV transmission, and new technologies that dramatically expand what clinics can accomplish with the same workforce to reach more patients. These innovations make the goal of ending the HIV epidemic truly within reach.

Of course, everything begins with an effective, funded, and functioning public health system -- business cannot replace that foundation. But built on top of it, the business community is uniquely positioned to help develop, design, and deploy these innovations at scale, turning these innovations into tangible, real-world impact for every community.

‍

Alchemy flips the traditional pharmacy model by putting ownership in the hands of community clinics. What inspired this approach, and how does it advance the fight to end HIV in the U.S.?  

The safety-net clinics we partner with -- Ryan White Program grantees, STD clinics, and Federally Qualified Health Centers -- are the critical frontline providers for HIV prevention and treatment in America. These specialized clinics offer an array of services that go above and beyond what traditional providers deliver to ensure patients have access to care.

And yet, so few of them have pharmacies inside their four walls -- even as they manage a medical condition in HIV that depends on reliable access to medicines. I'm convinced that friction in the U.S. pharmacy system is one of the biggest barriers to improving HIV outcomes today.

A clinic-owned pharmacy model addresses so many of these access barriers. It brings medication access directly alongside the care providers patients trust, creating a true one-stop shop for patients to manage their HIV treatment or prevention regimen. By flipping ownership back into the hands of the clinics, we ensure that as much of every 340B dollar as possible stays local. And it allows clinics, with support from innovation and infrastructure partners such as Alchemy, to maximize the reach of breakthrough innovations so patients benefit faster, more reliably, and where they need it most.

‍

Why is it important for Alchemy to be part of the U.S. Business Action to End HIV coalition?

No single business can solve this crisis alone. The Coalition gives us a platform to align with peers, share what’s working, and advocate for policies that strengthen—not weaken—the safety net.

Equally important, it signals that businesses see ending HIV not as charity work, but as part of building a healthier, more equitable, and more productive society. The economic and human costs of HIV are too great for us to treat this as a side effort -- it has to be central to how we think about building resilient communities and a stronger nation.

Finally, from a policy perspective, it has been a dynamic year for public health. We’ve found it highly effective to work through the Coalition to engage policymakers and ensure that well-intentioned reforms don’t inadvertently undermine the very clinics and patients they’re meant to support. For Alchemy, being part of this coalition connects our on-the-ground work with a national voice for smarter, more effective policy.

‍

Alchemy is working with patients who are often disconnected from the healthcare system—people experiencing homelessness, stigma, or chronic instability. How does Alchemy’s model break through those barriers?  

Trust and access. Because we operate directly with the clinics people already know and turn to, we eliminate layers of administrative friction and distance. Patients can walk into their community clinic and get care, counseling, and medication under one roof. That continuity matters especially when you’re dealing with persons living with stigma, unstable housing, or limited resources. We’ve seen patients who had dropped out of care come back, because suddenly the pharmacy isn’t a faceless counter across town; it’s part of their trusted clinic.

‍

What is Alchemy most proud of so far regarding your work to address HIV?

We’re proud that in just a short time, we’ve helped community clinics expand capacity and reach patients who might otherwise have fallen through the cracks. We’ve seen clinics reinvest their 340B savings into expanded peer recovery support & community health worker programs, mobile vans, and PrEP access programs. Those ripple effects are what make us proud—not just the pharmacy services we run, but the broader ecosystem we’re helping to strengthen.